Your browser doesn't support javascript.
loading
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial.
Szarek, Michael; Amarenco, Pierre; Callahan, Alfred; DeMicco, David; Fayyad, Rana; Goldstein, Larry B; Laskey, Rachel; Sillesen, Henrik; Welch, K Michael.
Afiliación
  • Szarek M; SUNY Downstate Health Sciences University, Brooklyn, New York. Electronic address: michael.szarek@downstate.edu.
  • Amarenco P; Paris University, Paris, France.
  • Callahan A; Meharry Medical College, Nashville, Tennessee.
  • DeMicco D; Pfizer, New York, New York.
  • Fayyad R; Pfizer, New York, New York.
  • Goldstein LB; University of Kentucky, Lexington, Kentucky.
  • Laskey R; Pfizer, New York, New York.
  • Sillesen H; University of Copenhagen, Copenhagen, Denmark.
  • Welch KM; Rosalind Franklin University, North Chicago, Illinois.
J Am Coll Cardiol ; 75(17): 2110-2118, 2020 05 05.
Article en En | MEDLINE | ID: mdl-32194196
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ataque Isquémico Transitorio / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Accidente Cerebrovascular / Atorvastatina Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ataque Isquémico Transitorio / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Accidente Cerebrovascular / Atorvastatina Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2020 Tipo del documento: Article